Creative Planning
MAIA icon

Creative Planning’s MAIA Biotechnology MAIA Stock Holding History

Creative Planning’s Portfolio MAIA Stock Details MAIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$40K Sell
28,602
-220
-0.8% -$406 ﹤0.01% 4005
2025
Q4 		$44.1K Buy
+28,822
New +$37.6K ﹤0.01% 3814

Other funds holding MAIA

SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
CWM
Centric Wealth Management Chicago, Illinois $501M AUM 15.27% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Creative Planning's MAIA Position: Q1 2026 in Review

Creative Planning reduced its MAIA Biotechnology (MAIA) stake by 0.76% in Q1 2026, selling an estimated $406 and leaving 28,602 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #4005.

Creative Planning first reported a position in MAIA in Q4 2025 and has held it in 2 quarters since. The position peaked at $44.1K in Q4 2025. 33 funds tracked by Wall St. Rank hold MAIA as of Q1 2026.

  • Creative Planning held 28,602 shares of MAIA Biotechnology worth $40K as of Q1 2026.
  • Creative Planning sold 220 MAIA Biotechnology shares in Q1 2026, an estimated $406.
  • MAIA Biotechnology made up ﹤0.01% of Creative Planning's portfolio in Q1 2026, its #4005 holding.
  • Creative Planning first reported a position in MAIA Biotechnology in Q4 2025 and has held it in 2 quarters since.
  • Creative Planning's MAIA Biotechnology position peaked at $44.1K in Q4 2025.
  • 33 funds tracked by Wall St. Rank held MAIA Biotechnology as of Q1 2026.

Based on Creative Planning's 13F filing for Q1 2026, filed 12 May 2026.